Clinical trial
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking…
NCT00056498 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00056498 |
|---|---|
| Title | Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine |
| Official title | Clozapine Treatment of Schizophrenic Patients |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH Ortho-McNeil Janssen Scientific Affairs, LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Placebo, Risperdal |
| Enrollment | 65 |
| Start date | Dec 1, 2001 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Mar 17, 2003 |
| Last update posted | Oct 1, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: